Suppr超能文献

注射用和局部外用局部麻醉药治疗急性牙痛:2 项系统评价。

Injectable and topical local anesthetics for acute dental pain: 2 systematic reviews.

出版信息

J Am Dent Assoc. 2023 Jan;154(1):53-64.e14. doi: 10.1016/j.adaj.2022.10.014.

Abstract

BACKGROUND

Local anesthesia is essential for pain control in dentistry. The authors assessed the comparative effect of local anesthetics on acute dental pain after tooth extraction and in patients with symptomatic irreversible pulpitis.

TYPES OF STUDIES REVIEWED

The authors searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and the US Clinical Trials registry through November 21, 2020. The authors included randomized controlled trials (RCTs) comparing long- vs short-acting injectable anesthetics to reduce pain after tooth extraction (systematic review 1) and evaluated the effect of topical anesthetics in patients with symptomatic pulpitis (systematic review 2). Pairs of reviewers screened articles, abstracted data, and assessed risk of bias using a modified version of the Cochrane risk of bias 2.0 tool. The authors assessed the certainty of the evidence using the Grading of Recommendations Assessment, Development and Evaluation approach.

RESULTS

Fourteen RCTs comparing long- vs short-acting local anesthetics suggest that bupivacaine may decrease the use of rescue analgesia and may not result in additional adverse effects (low certainty evidence). Bupivacaine probably reduces the amount of analgesic consumption compared with lidocaine with epinephrine (mean difference, -1.91 doses; 95% CI, -3.35 to -0.46; moderate certainty) and mepivacaine (mean difference, -1.58 doses; 95% CI, -2.21 to -0.95; moderate certainty). Five RCTs suggest that both benzocaine 10% and 20% may increase the number of people experiencing pain reduction compared with placebo when managing acute irreversible pulpitis (low certainty).

PRACTICAL IMPLICATIONS

Bupivacaine may be superior to lidocaine with epinephrine and mepivacaine with regard to time to and amount of analgesic consumption. Benzocaine may be superior to placebo in reducing pain for 20 through 30 minutes after application.

摘要

背景

局部麻醉对控制牙科疼痛至关重要。作者评估了局部麻醉剂在拔牙后急性牙痛和有症状不可逆性牙髓炎患者中的比较效果。

研究类型综述

作者检索了 MEDLINE、EMBASE、Cochrane 对照试验中心注册库和美国临床试验注册库,截至 2020 年 11 月 21 日。作者纳入了比较长作用和短作用注射用麻醉剂以减少拔牙后疼痛的随机对照试验(综述 1),并评估了局部麻醉剂在有症状牙髓炎患者中的效果(综述 2)。两名审稿人筛查文章、提取数据,并使用 Cochrane 偏倚风险 2.0 工具的修改版评估偏倚风险。作者使用推荐评估、制定和评价方法评估证据的确定性。

结果

四项比较长作用和短作用局部麻醉剂的随机对照试验表明,布比卡因可能减少急救镇痛药物的使用,且可能不会产生额外的不良反应(低确定性证据)。与含肾上腺素的利多卡因(差值,-1.91 剂;95%CI,-3.35 至-0.46;中等确定性)和甲哌卡因(差值,-1.58 剂;95%CI,-2.21 至-0.95;中等确定性)相比,布比卡因可能减少镇痛药物的用量。五项随机对照试验表明,在治疗急性不可逆性牙髓炎时,与安慰剂相比,10%和 20%苯佐卡因可能增加减轻疼痛的人数(低确定性)。

实际意义

布比卡因在镇痛药物的使用时间和剂量上可能优于含肾上腺素的利多卡因和甲哌卡因。苯佐卡因在应用后 20 至 30 分钟内可能优于安慰剂减轻疼痛。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验